This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Clarus Therapeutics Holdings 過去の業績
過去 基準チェック /06
主要情報
51.3%
収益成長率
84.5%
EPS成長率
| Pharmaceuticals 業界の成長 | 6.0% |
| 収益成長率 | 73.3% |
| 株主資本利益率 | n/a |
| ネット・マージン | -144.8% |
| 前回の決算情報 | 30 Jun 2022 |
収支内訳
収支内訳
Clarus Therapeutics Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 22 | 17 | -24 | 49 | 4 |
| 31 Mar 22 | 16 | -36 | 52 | 3 |
| 31 Dec 21 | 14 | -40 | 47 | 4 |
| 30 Sep 21 | 12 | -58 | 48 | 3 |
| 30 Jun 21 | 10 | -50 | 49 | 3 |
| 31 Mar 21 | 8 | -21 | 46 | 3 |
| 31 Dec 20 | 6 | -10 | 42 | 2 |
質の高い収益: CRXT.Q is currently unprofitable.
利益率の向上: CRXT.Q is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: Insufficient data to determine if CRXT.Q's year-on-year earnings growth rate was positive over the past 5 years.
成長の加速: Unable to compare CRXT.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: CRXT.Q is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (9.7%).
株主資本利益率
高いROE: CRXT.Q's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.